Self-jab drug approved for MS
Thousands of Australians with multiple sclerosis can now inject themselves with a government-funded drug to treat their symptoms instead of having to go to a doctor.
From today, the drug Plegridy will be funded on the Pharmaceutical Benefits Scheme, giving some MS patients the option to receive their injected treatment once a fortnight instead of several times a week.
The drug can also be given in a few seconds via a subcutaneous injection device, similar to an insulin injector pen, allowing patients to treat themselves.
